Table 1 ESAs classification per strength (IU/mcg) and price between originator & biosimilar products in 2012
Originators | |||
|---|---|---|---|
Brand | Strength | Active substance | Average hospital price/syringe (€)* |
150 MCG | 192.27 | ||
300 MCG | Darbepoetin α | 385.11 | |
ARANESP | 500 MCG | 635.49 | |
10.000 IU | 60.79 | ||
20.000 IU | Epoetin β | 149.68 | |
NEO RECORMON | 30.000 IU | 190.16 | |
60.000 IU | 342.25 | ||
10.000 IU | 53.9 | ||
20.000 IU | Epoetin α | 122.79 | |
30.000 IU | 196.55 | ||
EPREX | 40.000 IU | 212.42 | |
Biosimilars | |||
Brand | Strength | Active substance | Average hospital price/syringe (€)* |
ABSEAMED | 10.000 IU | 50.26 | |
20.000 IU | Epoetin α | 101.91 | |
30.000 IU | 152.87 | ||
40.000 IU | 203.83 | ||
10.000 IU | 47.41 | ||
20.000 IU | Epoetin α | 94.37 | |
BINOCRIT | 30.000 IU | 141.55 | |
40.000 IU | 188.73 | ||
10.000 IU | Epoetin ζ | 54.51 | |
RETACRIT | 40.000 IU | 255.54 | |